Literature DB >> 21983992

[Venous thrombembolism in tumour patients].

I Pabinger1, B Alt-Epping, F Demarmels Biasutti, F Langer, B Wörmann, H Riess.   

Abstract

Venous thrombembolism (VTE) is one of the most frequent complication in cancer patients. The current options in prophylaxis and therapy have to be balanced against the risks of major bleeding and the burden for the patients. The Gesellschaft für Thrombose- und Hämostaseforschung, the Deutsche Gesellschaft für Palliativmedizin and the German speaking Societies of Hematology and Oncology have recently published guidelines on VTE in cancer patients. Recommendations include diagnostics, individual prophylaxis and treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21983992     DOI: 10.5482/ha-1174

Source DB:  PubMed          Journal:  Hamostaseologie        ISSN: 0720-9355            Impact factor:   1.778


  2 in total

1.  [Risk of venous thromboembolism in patients with cancer treated with cisplatin: A systematic review and meta-analysis].

Authors:  M Wilhelm
Journal:  Strahlenther Onkol       Date:  2013-08       Impact factor: 3.621

Review 2.  [Deep vein thrombosis and pulmonary embolism : Diagnosis and treatment].

Authors:  Rupert Bauersachs
Journal:  Inn Med (Heidelb)       Date:  2022-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.